science

Ozanezumab

Ozanezumab is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Ozanezumab rather than just read about it. In short: Ozanezumab is a monoclonal antibody designed for the treatment of ALS and multiple sclerosis. Ozanezumab targets a protein called Neurite Outgrowth Inhibitor (NOGO-A) or Reticulon 4 (RTN4).

Key takeaways

Ozanezumab belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Ozanezumab to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Ozanezumab from memory before moving on to harder problems.

Reference excerpt

Ozanezumab is a monoclonal antibody designed for the treatment of ALS and multiple sclerosis. Ozanezumab targets a protein called Neurite Outgrowth Inhibitor (NOGO-A) or Reticulon 4 (RTN4). NOGO-A is a protein that in humans is encoded by the RTN4 gene that has been identified as an inhibitor of neurite outgrowth specific to the central nervous system. NOGO-A is found at higher than normal levels in persons with ALS. This drug was developed by GlaxoSmithKline (GSK) under the identifier GSK 1223249.

Mechanism From an announced phase II clinical trial by GSK:NOGO-A blocks neurons from growing toward muscle once the connection has been made. When motor neurons degenerate and the connection becomes weakened, NOGO-A would work against keeping that nerve/muscle contact strong. Increased NOGO-A has been observed in muscle of people with ALS and ozanezumab delayed symptom onset and improved survival in ALS model mice. Thus, it is hoped that it will preserve muscle function and slow the rate of ALS progression in humans.

(Monoclonal) Antibodies The antibodies in our body work by binding to foreign material (such as bacteria and viruses) so that it is no longer dangerous and can be 'labelled for destruction' for white blood cells. Monoclonal antibodies, like ozanezumab, are commercially designed antibodies which 'mop up' and bind to a specific target, in this case Nogo-A. This means that ozanezumab is able to help limit the loss of connections between motor neurones and muscles.

Administration Ozanezumab is an intravenous drug (administered directly into the blood stream).

Human Trials

Previous Trials Although some positive trends were observed in the exploratory exposure response analyses, given the small sample size, caution should be used in the interpretation of the exposure-response analyses. GlaxoSmithKline lists three reports with results of phase I studies:

A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in Patients with ALS. — 111330 A randomized, double-blind, placebo-controlled, single ascending dose study exploring the preliminary safety, tolerability and pharmacokinetics of GSK1223249 administered by intravenous (IV) infusion to patients with relapsing forms of multiple sclerosis, not on disease modifying therapy. — 112988 A randomized, single blind, placebo-controlled, single ascending dose/repeat dose cohort study to assess safety, tolerability, pharmacokinetics and immunogenicity of GSK1223249 in patients with relapsing forms of multiple sclerosis. — 114840

Current A Phase II trial completed in 2015.

References

Worked examples

Example 1 — a first encounter with Ozanezumab

Start with the simplest possible case. Write down what Ozanezumab claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Ozanezumab before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Ozanezumab ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Ozanezumab

In research: Ozanezumab appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Ozanezumab in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Ozanezumab is common in secondary-school and first-year university syllabi. It links to neighbouring topics Drugs developed by GSK plc, Drugs not assigned an ATC code, so understanding it makes those chapters shorter.
In everyday life: Look for Ozanezumab outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Ozanezumab” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Ozanezumab in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Ozanezumab means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Ozanezumab out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Ozanezumab in simple terms?

Ozanezumab is a monoclonal antibody designed for the treatment of ALS and multiple sclerosis. Ozanezumab targets a protein called Neurite Outgrowth Inhibitor (NOGO-A) or Reticulon 4 (RTN4).

Why does Ozanezumab matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Ozanezumab?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Ozanezumab.